Safety of nifedipine in angina pectoris: a meta-analysis.

Stason, W B; Schmid, C H; Niedzwiecki, D; Whiting, G W; Caubet, J F; Cory, D; Luo, D; Ross, S D; Chalmers, T C

Stason, W B; Schmid, C H; Niedzwiecki, D; Whiting, G W; Caubet, J F; Cory, D; Luo, D; Ross, S D; Chalmers, T C.

Affiliation

Stason WB; Harvard School of Public Health, Tufts University, Boston, Mass., USA.

Hypertension ; 33(1): 24-31, 1999 Jan.

Article in En | MEDLINE | ID: mdl-9931077

Subject(s)

Angina Pectoris/drug therapy; Calcium Channel Blockers/therapeutic use; Nifedipine/therapeutic use; Vasodilator Agents/therapeutic use; Adrenergic beta-Antagonists/administration & dosage; Angina Pectoris/complications; Angina Pectoris/mortality; Calcium Channel Blockers/adverse effects; Delayed-Action Preparations; Dosage Forms; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nifedipine/administration & dosage; Nifedipine/adverse effects; Nitrates/administration & dosage; Odds Ratio; Placebos; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Safety; Time Factors; Vasodilator Agents/adverse effects

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Vasodilator Agents / Calcium Channel Blockers / Nifedipine / Angina Pectoris Type of study: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Systematic_reviews Language: En Journal: Hypertension Year: 1999 Type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links